Results 11 to 20 of about 82,336 (259)

Infections and SLE

open access: yesAutoimmunity, 2005
Viral and bacterial infections may serve as an environmental trigger for the development or exacerbation of systemic lupus erythematosus (SLE) in the genetically predetermined individual. In addition, SLE patients are more prone to develop common (pneumonia, urinary tract infection, cellulitis, sepsis), chronic (tuberculosis), and opportunistic ...
Gisele Zandman-Goddard
exaly   +3 more sources

A review on SLE and malignancy [PDF]

open access: yesBest Practice and Research in Clinical Rheumatology, 2017
Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by autoantibody production, complement activation, and immune complex deposition. It predominantly affects young and middle-aged women. While improvements in the diagnosis and treatment of SLE have altered prognosis, morbidity and mortality rates remain higher ...
May Y Choi   +2 more
exaly   +3 more sources

The Link between Documentation Status, Occupation Status, and Healthcare Access for African migrants

open access: yesAfrican Human Mobility Review, 2021
The link between migrants’ legal and employment status, access to health and health outcomes is widely explored in the academic literature on migration and health. However, there are few, if any, studies examining this link within African states.
Paul Asquith   +3 more
doaj   +1 more source

CONTROL TECHNOLOGY ENERGY DISCHARGE OF A DEFIBRILLATOR

open access: yesСовременная наука и инновации, 2022
An innovative technology is proposed to stabilize the clinically significant impulse parameters for defibrillation and cardioversion purposes. The possibility of practical use of a clinically promising ascending ramp biphasic waveform has been ...
E. E. Gorokhov-Miroshnikov   +1 more
doaj   +1 more source

Prolongation of the QT interval under treatment with hydroxychloroquine in a patient with systemic lupus erythematosus: A case report [PDF]

open access: yesRomanian Journal of Rheumatology, 2022
Hydroxychloroquine (HCQ) is an antimalarial used in the treatment of patients with systemic lupus erythematosus (SLE). HCQ has a good safety profile and favorable results in terms of controlling clinical manifestations in SLE.
Ioan-Teodor Dragoi   +4 more
doaj   +1 more source

Diagnosis and Management of Cognitive Dysfunction In Systemic Lupus Erythematosus Patients

open access: yesClinical and Research Journal in Internal Medicine, 2022
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with diverse clinical manifestations. One of the frequent manifestations of SLE is cognitive dysfunction. Cognitive dysfunction is a hidden and often undiagnosed manifestation of SLE but
Perdana Aditya Rahman   +3 more
doaj   +1 more source

Neovascular Glaucoma as a Presenting Sign of Catastrophic Antiphospholipid Syndrome with a “Catastrophic” Heart Valve Finding

open access: yesCase Reports in Ophthalmology, 2021
We aimed to describe a case of neovascular glaucoma (NVG) as a first presenting sign of catastrophic antiphospholipid syndrome (CAPS) with heart valve aseptic vegetations known as Libman-Sacks endocarditis.
Anya Grinberg   +4 more
doaj   +1 more source

Renal Biopsy Findings in Patients with Hypothyroidism: Report of 16 cases [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Introduction: Hypothyroidism is prevalent in India. Its association with renal diseases though not very common but have been described in many studies.
Usha Singh   +6 more
doaj   +1 more source

Significance of determination of lipoprotein-associated Phospholipase A2 in patients with antiphospholipid syndrome [PDF]

open access: yesMedicinski Podmladak, 2023
Introduction: Lipoprotein-associated Phospholipase A2 (Lp-PLA2) is an essential mediator of inflammation, which has a vital role in inflammatory diseases of the vascular system.
Lević Marija   +3 more
doaj   +1 more source

SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment [PDF]

open access: yesAnnals of the Rheumatic Diseases, 2020
Inter-relationship between covid-19 and rheumatic diseases is an interesting topic in clinical rheumatology. We found that article ‘Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies’ is informative.
Joob, Beuy, Wiwanitkit, Viroj
openaire   +2 more sources

Home - About - Disclaimer - Privacy